qMIDS: A Digital Diagnostic Test for Oral Cancer

      Introduction: A critical surgical goal for oral cancer is achieving negative resection margins with no residual malignant cells, to prevent disease recurrence. The quantitative Malignancy Index Diagnostic System (qMIDS) is the first FOXM1 oncogene-based diagnostic test developed for quantifying oral squamous cell carcinoma. This highly sensitive technique converts gene expression into a digital index to quantify cancer risk.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect